Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fresenius Medical Care AG & Co. KGaA

24.46
+0.29001.20%
Pre-market: 24.880.4200+1.72%06:08 EDT
Volume:249.01K
Turnover:6.08M
Market Cap:14.35B
PE:25.82
High:24.47
Open:24.40
Low:24.24
Close:24.17
Loading ...

Company Profile

Company Name:
Fresenius Medical Care AG & Co. KGaA
Exchange:
NYSE
Establishment Date:
1996
Employees:
111513
Office Location:
Else-Kröner-Strasse 1,Bad Homburg,Hessen,Germany
Zip Code:
61352
Fax:
- -
Introduction:
Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Directors

Name
Position
Dieter Schenk
Vice Chairman
Stephan Sturm
Chairman, Director
Gerd Krick
Director
Rachel Empey
Director
Rolf A. Classon
Director
William P. Johnston
Director

Shareholders

Name
Position
Harry de Wit
Chief Executive Officer for the Asia-Pacific Segment
Katarzyna Mazur Hofsab
Chief Executive Officer for the EMEA Segment
Kent Wanzek
Chief Executive Officer of Global Manufacturing, Quality & Supply
Rice Powell
Chief Executive Officer
William Valle
Chief Executive Officer for the North America Segment
Helen Giza
Chief Financial Officer
Franklin W. Maddux
Global Chief Medical Officer
Olaf Schermeier
Chief Officer of Global Research & Development